AllDocs -> cancers

Acute Myeloid Leukaemia (AML) What is leukaemia ? Leukaemia is a cancer of cells in the bone marrow (the cells which develop into blood cells). Cancer is a disease of the cells in the body. There are many types of cancer which arise from different types of cell. What all cancers have in common is that the cancer cells are abnormal and do not respond to normal control mechanisms. Large numbers of cancer cells build up because they multiply 'out of control', or because they live much longer than normal cells, or both. With leukaemia , the cancerous cells in the bone marrow spill out into the bloodstream. There are several types of leukaemia . Most types arise from cells which normally develop into white blood cells. (The word leukaemia comes from a greek work which means 'white blood'.) If you develop leukaemia it is important to know exactly what type it is. This is because the outlook (prognosis) ...

Flow Cytometry Immunophenotyping of Leukaemia and Lymphoma A one-day meeting organised by the RMS and the Institute of Cancer Research The Conference Centre, Royal Marsden Hospital, London Monday 26 April 2004 Organiser: Ricardo Morilla, Department of Haemato-Oncology, Royal Marsden Hospital This well established annual flow cytometry meeting on immunophenotyping is ideal for people in the field who like to remain updated on the recent advances in immunophenotyping and flow cytometry in general. The aim of the meeting is to discuss the main aspects of the use of flow cytometry in the diagnosis of leukaemia and lymphoma. The intention is to present a balanced program which will include both research developments in the field and routine problems encountered by those using flow cytometers on a daily basis. The meeting will be of interest to experienced individuals and to those ...

abc H o d g k i n ’s disease & other lymphomas myeloma • myelodysplasia • aplastic anaemia the myeloproliferative disorders • the leukaemias Page 2 Acknowledgements The Leukaemia Research Fund gratefully acknowledges the help and advice of Professor A. V. Hoffbrand in reviewing this series of publications and the assistance of Professor A. Burnett, Professor D. C a t o v s k y, Professor J. Chessells, Professor J. Goldman, Professor E. Gordon-Smith, Professor A. Green, Dr A. Haynes, Professor G. Morg a n , Dr S. O'Brien, Professor J. Sweetenham and Professor J.L. Yin in the preparation of specific titles. Published by Leukaemia Research Fund , April 2001 43 Great Ormond Street L o n d o n WC1N 3JJ Tel: 020 7405 0101 Email: info@lrf.org . u k Fax: 020 7242 1488 Web: www. l r f . o rg . u k Registered Charity 216032 ...

www.ijmm.org HIV-1 INFECTION IN A PATIENT OF ACUTE LYMPHOCYTIC LEUKAEMIA MISSED BY HIV-SPOT AND HIV-SCAN RAPID TESTS *S Singh, V Kumari, N Singh Abstract A case of HIV-1 infection, presumably acquired through unsafe blood transfusion in an acute lymphocytic leukemia (ALL) patient, is reported here in whom the two rapid HIV antibody detection kits (HIV-spot and HIV-Scan) failed to diagnose the infection while the sample was strongly positive in microwell ELISA (detect- HIV) on the same day and was confirmed by western blot assay (NEW LAV BLOT-1). However, repeat sample after 15 days was found positive in all the tests. Though the rapid tests are preferred over microwell ELISA because of ease of performance and rapid availability of results, this report confirms low sensitivity of the two rapid tests. This suboptimal sensitivity, particularly in cases of early seroconversion, therefore, must ...

The Seven Steps Michelle Kenyon Patient Information w w w. k i n g s h e a l t h . c o m Page 2 Page 3 Acknowledgements A u t h o r I would like to take this opportunity to gratefully acknowledge the following people for their help, advice, support and encouragement. Professor GJ Mufti Dr A P a g l i u c a Dr S Devereux Nikki McKeag (EBMT (UK) Nurses and Allied Profession Group) RCN Haematology and Bone Marrow Transplant Nursing Forum I would also like to thank all of the patients who have read and endorsed the book during its development. Their valuable suggestions are incorporated. F i n a l l y, I would like to express my sincere thanks to Leukaemia Research Fund. In particular Sandra Gerscher and Dr David Grant. Michelle Kenyon, BMT Co-ordinator Nurse, King’s College Hospital Published by Leukaemia ...

Acta Haematol 2002;107:64–75 Cytogenetic and Molecular Monitoring of Residual Disease in Chronic Myeloid Leukaemia Jaspal Kaeda a Andrew Chase b John M. Goldman a a Department of Haematology, Imperial College at Hammersmith Hospital, London, b Leukaemia Research Unit, Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, UK Prof. John M. Goldman Department of Haematology Imperial College at Hammersmith Hospital Du Cane Road, London W12 0NN (UK) Tel. +44 20 8383 3238, E-Mail j.goldman@ic.ac.uk ABC Fax + 41 61 306 12 34 E-Mail karger@karger.ch www.karger.com © 2002 S. Karger AG, Basel 0001–5792/02/1072–0064$18.50/0 Accessible online at: www.karger.com/journals/aha Key Words Chronic myeloid leukaemia W Ph chromosome ...

The Journal Protocol Reviews eResearch Archive Info for Authors Profile Help Feedback The Journal Current Issue Supplements Back Issues Contents in full Talking points Original research News Editorial and review Correspondence Clinical picture Dissecting room Search Journal Subscribe E-Toc Log Out Jobs Awards and Announcements Conferences Press Services General Info Free Sample Contact Us Home The Journal Back Issues Original research Volume 363, Number 9403 10 January 2004 Jenny A Orchard, Rachel E Ibbotson, Zadie Davis, Adrian Wiestner, Andreas Rosenwald, Peter W Thomas, Terry J Hamblin, Louis M Staudt, David G Oscier Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK (J A Orchard FRCPath, R E Ibbotson PhD, Z Davis BSc, T ...

A Response to the Magnox Sites RSA Consultation Annex 1: Radiation and Health © Mobbs Environmental Investigations, August 2000 page A1-143 Incidence of leukaemia in young people around La Hague nuclear waste reprocessing plant: a sensitivity analysis. Jean-Francois Viel/ Dominique Pobel. Statistics in Medicine 1995; 14, 2459-2472 Page 2 A Response to the Magnox Sites RSA Consultation Annex 1: Radiation and Health © Mobbs Environmental Investigations, August 2000 page A1-144 Page 3 A Response to the Magnox Sites RSA Consultation Annex 1: Radiation and Health © Mobbs Environmental Investigations, August 2000 page A1-145 Page 4 A Response to the Magnox Sites RSA Consultation Annex 1: Radiation and Health © Mobbs Environmental Investigations, August 2000 page A1-146 ...

A Response to the Magnox Sites RSA Consultation Annex 1: Radiation and Health © Mobbs Environmental Investigations, August 2000 page A1-120 Case control study of leukaemia among young people near La Hague nuclear reprocessing plant: the environmental hypothesis revisited. Dominique Pobel/Jean-Francois Viel. British Medical Journal, 11/1/97; 314, 101-106 Page 2 A Response to the Magnox Sites RSA Consultation Annex 1: Radiation and Health © Mobbs Environmental Investigations, August 2000 page A1-121 Page 3 A Response to the Magnox Sites RSA Consultation Annex 1: Radiation and Health © Mobbs Environmental Investigations, August 2000 page A1-122 Page 4 A Response to the Magnox Sites RSA Consultation Annex 1: Radiation and Health © Mobbs Environmental Investigations, ...

Abstract. More than a decade of experimental work in an inbred subline of Sprague-Dawley rats having high incidence of spontaneous T-cell lymphoma/ leukaemia is reviewed. Longitudinal follow-up of biological charac- teristics (growth, survival, haematology) of both multi- ple cases of primary disease and s.c. passaged lym- phomas as well as comparative immunophenotypic and karyotypic studies are concluded. In these T-cell lym- phomas (mostly CD4 positive), arising on the same genetic background of the inbred SD strain, the aberra- tions involving chromosome 11 have been recognized as a typical non-random cytogenetic marker. This unique rat model of lymphoblastic lymphomas/leukaemias, rel- evant to human pathology, seems to be very suitable for testing different anticancer therapeutic strategies, as it is documented by results of a number of various protocols conducted ...

Page 1 of 2 of Instrument No.59 of 2003 Instrument No.59 of 2003 Amendment of Statement of Principles concerning CHRONIC LYMPHOID LEUKAEMIA Veterans’ Entitlements Act 1986 1. As directed by the Specialist Medical Review Council, under subsection 196W(4) of the Veterans’ Entitlements Act 1986 (the Act), the Repatriation Medical Authority amends, pursuant to subsection 196B(10) of the Act, Instrument No.67 of 2001 by: A. in paragraph 5, inserting a new factor (b) as follows: “(b) receiving greater than 25.0 microtesla years of exposure to magnetic fields generated at extremely low frequencies where this dose was accumulated at least 10 years before the clinical onset of chronic lymphoid leukaemia ; or” B. in paragraph 5, renumbering existing factor (b) as (c); C. in paragraph 8, inserting after the definition of “ICD-10-AM ...

l del file contenuto in http://www.supercourse.cn/SupercoursePPT/6011-7001/6301.ppt . G o o g l e crea automaticamente la versione .html dei documenti durante la scansione del Web. Per inserire un segnalibro o un collegamento alla pagina, utilizzare il seguente URL: http://www.google.com/search?q=cache:g8QilRs_q0AJ:www.supercourse.cn/SupercoursePPT/6011-7001/6301.ppt+leukaemia+filetype:pdf+OR+filetype:doc+OR+filetype:ppt+OR+filetype:xls+OR+filetype:rtf&hl=it&ct=clnk&cd=339&lr=lang_en Google non è collegato agli autori di questa pagina e non è responsabile del suo contenuto. I termini specificati sono presenti solamente in collegamenti che rimandano alla seguente pagina: leukaemia Dr Heather O Dickinson My web page Department of Child Health University of Newcastle Audit of cancer registrations notified by National Health Service Central Register in England & Wales ...

Is indoor radon linked to leukaemia in children and adults? - A review of the evidence Denis L Henshaw and Janet E Allen H H Wills Physics Laboratory, University of Bristol, Tyndall Avenue, Bristol, BS8 1TL, UK, Tel: +44 (0) 117 9260353; Fax: + 44 (0) 117 9251723; e-mail: d.l.henshaw@bris.ac.uk Abstract The evidence linking indoor radon exposure to childhood and adult leukaemia is reviewed. At the UK average indoor exposure of 20 Bq m -3 , it is estimated that the radon derived equivalent dose accrued to the fetus is 106 µSv. The equivalent dose rate to adult bone marrow 130 µSv y -1 . Standard radiation risk factors suggest that 5% of childhood and 4% of adult leukaemia is linked to radon at 20 Bq m -3 exposure. Geographical studies generally support such a link at about this magnitude. A number of case-control studies have been carried out but ...

C A S E R E P O R T JIACM 2003;4(4):340-2 *Medical Oncologist, Rajiv Gandhi Cancer Institute and Research Centre,Sector V,Rohini,Delhi-110 085. Erythrodysesthesia associated with Cytosine Arabinoside during Therapy of Acute Myeloid Leukaemia – A report of 2 Cases Vineet Talwar* Abstract Acral erythema or erythrodysesthesia is a common occurrence in patients of AML treated with high dose cytarabine where bullae formation may be a part of its evolution.Though,most of the time it is a self limiting condition,rarely it may be severeenough to cause ulceration of the digits and may give rise toseveredistress to the patient possibly due to ischaemia.Avoidance of the culprit drug is required in such a severesituation. Introduction In 1974, Zuehlke 1 first described an erythematous eruption of palms and soles associated with the administration ...

Quinacrine banding of leukemic cells from nine pa- tients with chronic myeloid leukemia (CML) revealed that the material from the Philadelphia (Ph1) chromo- some (no. 22) was translocated to chromosome 9, not deleted. This translocation -gas present in chronic and acute phases ofCML and was absent from peripheral lymphocytes. (The 5(7indicates that this paper has been cited in over 750 publications.) Janet 0. Rowley Department of Medicine University of Chicago Medical Center Chicago, IL 60637 After a very rocky start, my paper on the nature of the Philadelphia (Ph’) chromosome in chronic myeloid leukemia (CML) has led to scientific as well as personal success. I had spent a year’s sabbatical (1970-1971) in Oxford learning the new chromo- some banding ...

a report by Professor Martin J S Dyer Professor of Haemato-Oncology and Honorary Consultant Physician, Medical Research Council (MRC) Toxicology Unit, University of Leicester Risk Stratification in the Treatment of Chronic Lymphocytic Leukaemia B U S I N E S S B R I E F I N G : E U R O P E A N P H A R M A C O T H E R A P Y 2 0 0 5 1 Reference Section Martin J S Dyer is Professor of Haemato-Oncology and Honorary Consultant Physician in the Medical Research Council (MRC) Toxicology Unit at the University of Leicester. His research interests are the antibody therapy and molecular genetics of B-cell malignancy. He worked for 11 years at the Royal Marsden Hospital with Professor Daniel Catovsky, following his training in medicine at Oxford and Cambridge Universities in the UK. Introduction One of the greatest medical ...

J. Meletis et al 394 D. Marisavljevi} et al Haema 2003; 6(3): 394-397 Case report Spontaneous clinical remission of chronic lymphocytic leukaemia Dragomir Marisavljevi}, Ivo Elezovi}, Nada Kraguljac Institute of Haematology, Clinical Center of Serbia, 11000 Belgrade, Yugoslavia Abstract. Spontaneous remission of haematologic malignancy is extremely rare. Spontaneous remission of chronic lymphocytic leukaemia (CLL) has been associated with viral infection, immunization and new primary carcinoma. We report two cases of spontaneous regression of CLL, observed after 20 and 9 years from diagnosis. Spontaneous regression of CLL was documented by clinical and haematological data and was not associated with viral infection or secondary malignancy. Both patients are alive and without signs of CLL, three and four years after spontaneous regression of the disease. Authors discussed ...

1 Childhoodleukaemia - communicating with a worried public Burls, Amanda J.E. Department of Public Health and Epidemiology University of Birmingham Edgbaston Birmingham B15 2TT United Kingdom A.J.Burls@bham.ac.uk 1. Introduction This presentation is a case-history of an attempt by a local health authority in the U.K. to deal with high levels of public anxiety about a cluster of childhood leukaemia in Northampton by a risk communication strategy. Usually, in similar circumstances of intense public demand and extensive adverse publicity, health authority’s have responded by setting up, predictably inconclusive, epidemiological studies. Despite intense public, political, media and management pressure to do just this, we chose rather to educate the public about disease clusters and the limitations of epidemiological methods. This involved working with the community ...

Abstract. In order to assess the effect of the DNA polymerase inhibitor aphidicolin on resistance to cytosine arabinoside, blast cells from 15 children with ALL and 9 with AML were exposed to a range of concentrations of ara-C ± aphidicolin. Cell survival was measured using the MTT assay. Aphidicolin significantly increased sensitivity to ara-C in blast cells from both ALL (p=0.001) and AML (p<0.01). The median fold increase (sensitisation ratio) for ALL was 3.4 (range 1.2-13.6) compared to 12.4-fold (range 6.0-148) for AML blasts (p=0.005). There was a striking relationship between increasing ara-C resistance and increasing effect of aphidicolin in AML (p<0.001) but not ALL (p>0.05). These remarkable results suggest that aphidicolin should be considered for future clinical trials as a modulator of ara-C resistance, particularly in AML. Introduction Drug resistance remains a major ...

Appendix Cancer survival by Area Health Services in NSW 1994 – 98 The Cancer Council NSW 64 Leukaemia • The five-year relative survival from leukaemia in NSW between 1994 and 2000 was 36.5% • The adjusted relative risks of excess death after shrinking were lower in Northern Sydney (12%, 38 fewer deaths) and Hunter (13%, 27 fewer deaths) • An additional 249 patients with leukaemia would be expected to survive to five years after diagnosis in NSW if the State average risk was shifted to the 20 th centile of the distribution • There were 3,609 new cases of leukaemia in NSW in 1994 to 1998 (2,094 males and 1,515 females) and 2,183 deaths (1,261 males and 922 females) • There was no area variation in the excess number of new cases in males, and there were no Area Health Services in which the number of new cases in females was different from expected ...

C:\Documents and Settings\Stone Janey \My Documents\ALLG\Tissue Bank\Agreement for TB sample access.doc 23/09/2003 AGREEMENT FOR AMP LEUKAEMIA & LYMPHOMA TISSUE BANK SAMPLE USE & ACKNOWLEDGMENT. I, have read, understood, and agree with the ‘Conditions of Use of Tissue Bank Samples’. I additionally agree to the following: 1. That I will use the specimens provided to me by the Tissue Bank only in the manner detailed in my application for these specimens. I will not give or sell them to a third party or use them for any purpose not specified in the application without prior specific approval. 2. That I will not, in any way, attempt to identify the patients from whom these samples were obtained, nor will I attempt to gain any personal information regarding these patients other than that obtained through the Tissue Bank. Clinical information pertaining to these patients and pertinent ...

Page 1 of 4 of Instrument No.16 of 2003 Instrument No.16 of 2003 Revocation and Determination of Statement of Principles concerning CHRONIC MYELOID LEUKAEMIA Veterans’ Entitlements Act 1986 1. The Repatriation Medical Authority under subsection 196B(3) of the Veterans’ Entitlements Act 1986 (the Act): (a) revokes Instrument No.8 of 1997; and (b) determines in its place the following Statement of Principles. Kind of injury, disease or death 2. (a) This Statement of Principles is about chronic myeloid leukaemia and death from chronic myeloid leukaemia . (b) For the purposes of this Statement of Principles, “chronic myeloid leukaemia ” means a haematological neoplasm characterised by the clonal proliferation and accumulation of mature myeloid cells and their progenitors in the peripheral ...

Page 1 of 4 of Instrument No.15 of 2003 Instrument No.15 of 2003 Revocation and Determination of Statement of Principles concerning CHRONIC MYELOID LEUKAEMIA Veterans’ Entitlements Act 1986 1. The Repatriation Medical Authority under subsection 196B(2) of the Veterans’ Entitlements Act 1986 (the Act): (a) revokes Instrument No.7 of 1997; and (b) determines in its place the following Statement of Principles. Kind of injury, disease or death 2. (a) This Statement of Principles is about chronic myeloid leukaemia and death from chronic myeloid leukaemia . (b) For the purposes of this Statement of Principles, “chronic myeloid leukaemia ” means a haematological neoplasm characterised by the clonal proliferation and accumulation of mature myeloid cells and their progenitors in the peripheral ...

Page 1 of 4 of Instrument No.170 of 1996. Instrument No.170 of 1996 Revocation and Determination of Statement of Principles concerning ACUTE MYELOID LEUKAEMIA ICD CODES: 205.0, 206.0, 207.0, 207.2, 208.0 Veterans’ Entitlements Act 1986 1. The Repatriation Medical Authority under subsection 196B(3) of the Veterans’ Entitlements Act 1986 (the Act): (a) revokes Instrument No.36 of 1994, Instrument No.270 of 1995, and Instrument No.120 of 1996; and (b) determines the following Statement of Principles. Kind of injury, disease or death 2. (a) This Statement of Principles is about acute myeloid leukaemia and death from acute myeloid leukaemia . (b) For the purposes of this Statement of Principles, “acute myeloid leukaemia ” means a morphologically heterogenous group of malignant neoplasms, attracting ICD ...

Page 1 of 4 of Instrument No.7 of 1997. Instrument No.7 of 1997 Revocation and Determination of Statement of Principles concerning CHRONIC MYELOID LEUKAEMIA ICD CODES: 205.1, 206.1, 208.1 Veterans’ Entitlements Act 1986 1. The Repatriation Medical Authority under subsection 196B(2) of the Veterans’ Entitlements Act 1986 (the Act): (a) revokes Instrument Nos.99 and 126 of 1995; and (b) determines the following Statement of Principles. Kind of injury, disease or death 2. (a) This Statement of Principles is about chronic myeloid leukaemia and death from chronic myeloid leukaemia . (b) For the purposes of this Statement of Principles, “chronic myeloid leukaemia ” means a haematological neoplasm characterised by the clonal proliferation and accumulation of mature myeloid cells and their progenitors, and ...

Page 1 of 4 of Instrument No.8 of 1997. Instrument No.8 of 1997 Revocation and Determination of Statement of Principles concerning CHRONIC MYELOID LEUKAEMIA ICD CODES: 205.1, 206.1, 208.1 Veterans’ Entitlements Act 1986 1. The Repatriation Medical Authority under subsection 196B(3) of the Veterans’ Entitlements Act 1986 (the Act): (a) revokes Instrument Nos.100 of 1995 and 148 of 1996; and (b) determines the following Statement of Principles. Kind of injury, disease or death 2. (a) This Statement of Principles is about chronic myeloid leukaemia and death from chronic myeloid leukaemia . (b) For the purposes of this Statement of Principles, “chronic myeloid leukaemia ” means a haematological neoplasm characterised by the clonal proliferation and accumulation of mature myeloid cells and their progenitors, ...